Skip to main content
. 2019 Oct 17;145(12):1170–1178. doi: 10.1001/jamaoto.2019.3020

Table 1. Study Population Demographics.

Variable Patients, No./Total No. (%)
Age, y
50-64 105/274 (38.3)
≥65 169/274 (61.7)
Sex, No. (%)
Male 206/274 (75.2)
Female 68/274 (24.8)
Marital status
Married or common-law marriage 167/234 (71.4)
Other 67/234 (28.6)
Educational level
No postsecondary education 92/214 (43.0)
Postsecondary education 122/214 (57.0)
Tumor site
Mucosal 158/271 (58.3)
Nonmucosal 113/271 (41.7)
Microvascular reconstruction
Yes 212/274 (77.4)
No 62/274 (22.6)
Postoperative complications (all grades)
Yes 114/274 (41.6)
No 160/274 (58.4)
Comorbidity scorea
None or mild 171/274 (62.4)
Moderate or severe 103/274 (37.6)
Disease status 3 mo after surgery
Alive with disease 26/259 (10.0)
Alive without disease 225/259 (86.9)
Deceased from disease 4/259 (1.5)
Deceased from other causes 4/259 (1.5)
Disease status 6 mo after surgery
Alive with disease 25/227 (11.0)
Alive without disease 187/227 (82.4)
Deceased from disease 14/227 (6.2)
Deceased from other causes 1/227 (0.4)
Disease status 12 mo after surgery
Alive with disease 16/208 (7.7)
Alive without disease 166/208 (79.8)
Deceased from disease 22/208 (10.6)
Deceased from other causes 4/208 (1.9)
a

Determined from the Adult Comorbidity Evaluation–27 tool.